Venous thromboembolism treatment in patients with cancer: reflections on an evolving landscape by Agnes Y.Y. Lee

Get full text

Cancer‐associated venous thromboembolism: Treatment and prevention with rivaroxaban by Rupert Bauersachs, Alok A. Khorana, Agnes Y. Y. Lee, Gerald Soff

Get full text

Vaccine‐induced prothrombotic immune thrombocytopenia without thrombosis may not require immune modulatory therapy: A case report by Chieh Min Benjamin Lai, Agnes Y.Y. Lee, Stephen B.I. Parkin

Get full text

Dual direct oral anticoagulant therapy in challenging thrombosis: a case series by Nicholas L.J. Chornenki, Heather McPhaden, Erica A. Peterson, Chieh Min Benjamin Lai, Agnes Y.Y. Lee

Get full text

COSIMO – patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional study by Alexander T. Cohen, Anthony Maraveyas, Jan Beyer-Westendorf, Agnes Y. Y. Lee, Lorenzo G. Mantovani, Miriam Bach, on behalf of the COSIMO Investigators

Get full text

Antiphospholipid syndrome, monoclonal gammopathy, and cryoglobulinemia overlap leading to recurrent cutaneous microvascular thrombosis: A case report and retrospective cohort study by Alexandra Bohm, Bo Angela Wan, Amir Karin, Lauren J. Lee, Agnes Y. Y. Lee, Edward M. Conway, Chieh Min Benjamin Lai

Get full text

Treatment Algorithm in Cancer-Associated Thrombosis: Updated Canadian Expert Consensus by Marc Carrier, Normand Blais, Mark Crowther, Petr Kavan, Grégoire Le Gal, Otto Moodley, Sudeep Shivakumar, Deepa Suryanarayan, Vicky Tagalakis, Cynthia Wu, Agnes Y. Y. Lee

Get full text

Reduced fixed dose tocilizumab 400 mg IV compared to weight-based dosing in critically ill patients with COVID-19: A before-after cohort study by Sophie Stukas, George Goshua, Angus Kinkade, Rebecca Grey, Gregory Mah, Catherine M. Biggs, Shahin Jamal, Sonny Thiara, Tim T.Y. Lau, Jolanta Piszczek, Nilu Partovi, David D Sweet, Agnes Y.Y. Lee, Cheryl L. Wellington, Mypinder S. Sekhon, Luke Y.C. Chen

Get full text

Anticoagulation practice patterns in COVID‐19: A global survey by Rachel P. Rosovsky, Kristen M. Sanfilippo, Tzu Fei Wang, Sandeep K. Rajan, Surbhi Shah, Karlyn A. Martin, Fionnuala Ní Áinle, Menno Huisman, Beverley J. Hunt, Susan R. Kahn, Barry Kevane, Agnes Y. Y. Lee, Claire McLintock, Lisa Baumann Kreuziger

Get full text

Randomized trials of therapeutic heparin for COVID‐19: A meta‐analysis by Michelle Sholzberg, Bruno R. daCosta, Grace H. Tang, Hassan Rahhal, Musaad AlHamzah, Lisa Baumann Kreuziger, Fionnuala Ní Áinle, Mozah Obaid Almarshoodi, Paula D. James, David Lillicrap, Marc Carrier, Andrew Beckett, Michael Fralick, Saskia Middeldorp, Agnes Y. Y. Lee, Kevin E. Thorpe, Elnara Márcia Negri, Mary Cushman, Peter Jüni, the RAPID Trial Investigators

Get full text

Rivaroxaban Versus Low-Molecular-Weight Heparins in a Broad Cohort of Patients With Cancer-Associated Venous Thromboembolism: An Analysis of the OSCAR-US Program by Kimberly Snow Caroti PharmD, Alok A. Khorana MD, Cecilia Becattini MD, Agnes Y.Y. Lee MD, Anders Ekbom MD, Marc Carrier MD, Alexander T. Cohen MD, Christopher Brescia BS, Khaled Abdelgawwad MSc, MBA, George Psaroudakis PhD, Marcela Rivera PhD, Bernhard Schaefer BS, Gunnar Brobert PhD, Craig I. Coleman PharmD

Get full text